No Data
No Data
Polyrizon Ltd. Signs Manufacturing Agreement With Eurofins CDMO to Support PL-14 Clinical Trial Preparation
Polyrizon Enters Into GMP Manufacturing Agreement for CTM Supply of Its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Express News | Polyrizon Enters Into Gmp Manufacturing Agreement for Ctm Supply of Its Pl-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Polyrizon | 6-K: Report of foreign private issuer (related to financial reporting)
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket